Women’s health experts have issued a warning about the limitations of the first-of-its-kind endometriosis treatment pill, ...

Ryeqo drug is hailed as a ‘potential step-change’ in how endometriosis is treated A new pill designed to transform the ...

Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap ...

Hoorah for some positive women's health news! A new endometriosis pill has been made available on the NHS in England, in what ...

Thousands of Australian women will soon save hundreds – and in some cases, thousands – of dollars a year for fertility, ...

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

We believe quality journalism should be available to everyone, paid for by those who can afford it. A first-of-its-kind pill for endometriosis has been approved for NHS use, offering hope for people ...

Ryeqo is likely to start being prescribed to patients in Wales within two months, but there will be restrictions on who can ...

On average, Nice says it takes nine years from symptom onset to get a diagnosis of endometriosis. According to the NHS ...

A new pill designed to transform the treatment of endometriosis has been approved for use on the NHS. The combination drug ...

A FIRST-of-its-kind pill designed to transform treatment of agonising endometriosis will be available on the NHS. The condition affects an estimated 1.5 million women in the UK, causing intense ...

The new tablet, known as Ryeqo or relugolix-estradiol-norethisterone, has been approved to treat women of reproductive age ...